Jefferies Financial Group Inc. Amicus Therapeutics, Inc. Transaction History

Jefferies Financial Group Inc.

  • $13.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$9.97 - $14.52 $242,061 - $352,531
-24,279 Reduced 45.15%
29,494 $418,000
Q3 2023

Nov 14, 2023
SELL
$11.78 - $13.86 $453,671 - $533,776
-38,512 Reduced 41.73%
53,773 $653,000
Q2 2023

Aug 14, 2023
BUY
$10.72 - $13.3 $989,295 - $1.23 Million
92,285 New
92,285 $1.16 Million

Others Institutions Holding FOLD

# of Institutions
312
Shares Held
312M
Call Options Held
516K
Put Options Held
833K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.64B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email